Ancient Peruvian healers practiced trepanation, a surgical procedure which involved removing a section of the cranial vault with a hand drill, over 1000 years ago in order to treat a variety of ailments, a new study reports.
Keck Medicine announces they will perform a ground breaking surgical implant for epilepsy patients.
A new neuroimaging technique allows neurosurgeons to see neural connections prior to surgery, thus preserving and protecting the brain's critical functions when operating.
Researchers have identified a new and more accurate way to determine which portions of the brain suffer from epilepsy. The information could provide patients and doctors with better information as to whether temporal lobe surgery will provide the best treatment outcome.
Researchers develop a steerable needle robot which can penetrate the brain and suction away blood clots.
Neurosurgeons have developed a new way to perform deep brain stimulation surgeries. The new technique allows for more accurate placement of the electrodes in the brain and is likely to be safer for patients.
Researchers recently developed a system for observing real-time brain activity in a live mouse. The device could prove useful in studying new treatments for Alzheimer's and other neurodegenerative diseases.
Working with patients with electrodes implanted in their brains, researchers show that areas of the brain work simultaneously to recall memories. The approach promises new insights into how we remember details of time and place.
Doctors performed the first-ever FDA approved Schwann cell transplantation in a patient with a new spinal cord injury. The procedure is a Phase 1 clinical trial designed to evaluate the safety and feasibility of transplanting the patient’s own Schwann cells.
Electrical stimulation using extradural electrodes—placed underneath the skull but not implanted in the brain, is a safe approach with meaningful benefits for patients with Parkinson's disease according to new research.
When aggressive, malignant tumors appear in more than one location in the brain, patient survival tends to be significantly shorter than when the disease starts as a single tumor, even though patients in both groups undergo virtually identical treatments, according to research at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Research Institute.
A new probe developed uses an innovative fluorescence-reading technology to help brain surgeons distinguish cancerous tissue from normal tissue. The probe tool, now already in use at the Cancer Center for brain surgery, may one day be used for surgeries for a variety of cancers.
